Navigation Sciences, founded to innovate in the field of image-guided, minimally invasive surgery, focuses on developing advanced surgical technologies. Their core mission is to enhance precision in cancer surgeries, particularly lung and other soft tissue cancers, through the NaviSci™ system. This system utilizes real-time GPS navigation and precise margin control to improve surgical outcomes, reduce early-stage cancer recurrence, and conserve lung function. The company's market focus is on addressing unmet needs in soft tissue surgery.
Notable affiliated individuals and investors include experts in surgical technology and healthcare innovation. Key achievements for Navigation Sciences include the successful completion of a clinical feasibility trial for the NaviSci™ system. This milestone demonstrates the system's potential to significantly improve surgical workflows and patient outcomes. The overall impact of Navigation Sciences lies in its potential to revolutionize cancer surgery, offering more precise and less invasive options for patients and surgeons alike.